Deal Snapshot: It has been a tough few months for the Swiss company since Johnson & Johnson pulled out of their epilepsy pact but long-time partner Indivior has run to its rescue and will advance a substance use disorder compound.
Geneva is home to Addex • Source: Shutterstock
Who: Addex/Indivior
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
